SHARP SURGICAL INSTRUMENTS LIMITED

Company Registration Number:
12444285 (England and Wales)

Unaudited statutory accounts for the year ended 29 February 2024

Period of accounts

Start date: 1 March 2023

End date: 29 February 2024

SHARP SURGICAL INSTRUMENTS LIMITED

Contents of the Financial Statements

for the Period Ended 29 February 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

SHARP SURGICAL INSTRUMENTS LIMITED

Directors' report period ended 29 February 2024

The directors present their report with the financial statements of the company for the period ended 29 February 2024

Principal activities of the company

Retail sale of medical and orthopaedic goods in specialised stores



Directors

The director shown below has held office during the whole of the period from
1 March 2023 to 29 February 2024

CHAUHAN Ushaben Brijiesh


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
29 October 2026

And signed on behalf of the board by:
Name: CHAUHAN Ushaben Brijiesh
Status: Director

SHARP SURGICAL INSTRUMENTS LIMITED

Profit And Loss Account

for the Period Ended 29 February 2024

2024 2023


£

£
Turnover: 980,000 850,000
Cost of sales: ( 560,000 ) ( 430,000 )
Gross profit(or loss): 420,000 420,000
Distribution costs: ( 46,500 ) ( 40,000 )
Administrative expenses: ( 197,100 ) ( 176,000 )
Other operating income: 0 0
Operating profit(or loss): 176,400 204,000
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0
Profit(or loss) before tax: 176,400 204,000
Tax: ( 42,191 ) ( 38,760 )
Profit(or loss) for the financial year: 134,209 165,240

SHARP SURGICAL INSTRUMENTS LIMITED

Balance sheet

As at 29 February 2024

Notes 2024 2023


£

£
Fixed assets
Tangible assets: 3 600,000 600,000
Investments:   0 0
Total fixed assets: 600,000 600,000
Current assets
Stocks:   0 0
Debtors: 4 137,000 117,000
Cash at bank and in hand: 190,000 115,000
Investments:   0 0
Total current assets: 327,000 232,000
Creditors: amounts falling due within one year: 5 ( 147,551 ) ( 111,760 )
Net current assets (liabilities): 179,449 120,240
Total assets less current liabilities: 779,449 720,240
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): 779,449 720,240
Capital and reserves
Called up share capital: 600,000 600,000
Profit and loss account: 179,449 120,240
Total Shareholders' funds: 779,449 720,240

The notes form part of these financial statements

SHARP SURGICAL INSTRUMENTS LIMITED

Balance sheet statements

For the year ending 29 February 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 29 October 2026
and signed on behalf of the board by:

Name: CHAUHAN Ushaben Brijiesh
Status: Director

The notes form part of these financial statements

SHARP SURGICAL INSTRUMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SHARP SURGICAL INSTRUMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 1 1

SHARP SURGICAL INSTRUMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 March 2023 600,000 600,000
Additions
Disposals
Revaluations
Transfers
At 29 February 2024 600,000 600,000
Depreciation
At 1 March 2023
Charge for year
On disposals
Other adjustments
At 29 February 2024
Net book value
At 29 February 2024 600,000 600,000
At 28 February 2023 600,000 600,000

SHARP SURGICAL INSTRUMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

4. Debtors

2024 2023
£ £
Trade debtors 120,000 105,000
Prepayments and accrued income 10,000 12,000
Other debtors 7,000 0
Total 137,000 117,000
Debtors due after more than one year: 0 0

SHARP SURGICAL INSTRUMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

5. Creditors: amounts falling due within one year note

2024 2023
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 85,000 65,000
Taxation and social security 42,191 38,760
Accruals and deferred income 10,360 8,000
Other creditors 10,000 0
Total 147,551 111,760